.Merck beats revenues desires, brings up sales outlook on solid demand for best medicines like Keytruda CNBCMerck & Co. (MRK United States) Beats Income Estimates as Keytruda Purchases Rise BloombergMerck Inventory: Pharma Titan Posts Powerful Results, Yet Expectation Falls Short Client's Service DailyMerck Announces Second-Quarter 2024 Financial Outcomes Yahoo FinanceMerck beats earnings and also purchases requirements surrounded by Keytruda strong point, but offers mixed full-year overview MarketWatch.